Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment and sampling protocols for transgenic mutation assays.

John A Heddle1, Hans-Joerg Martus, George R Douglas

  • 1Department of Biology, York University, Toronto, Ontario M3J 1P3, Canada. jheddle@yorku.ca

Environmental and Molecular Mutagenesis
|January 29, 2003
PubMed
Summary

Standard transgenic mutation assays may lose sensitivity for some chemicals. Continuing chemical treatments until sampling time is proposed to maintain assay sensitivity for detecting mutagens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Summary of Major Conclusions From the 8th International Workshop on Genotoxicity Testing (IWGT), Ottawa, Canada.

Environmental and molecular mutagenesis·2026
Same author

Inclusion of a recovery period after pulse treatment in the primary human lymphocyte micronucleus assay covers potential cell cycle delays without loss of sensitivity.

Mutagenesis·2026
Same author

An evaluation of the utility of blood concentration of somatic mutagens to inform germ cell mutagenic hazard.

Regulatory toxicology and pharmacology : RTP·2025
Same author

Temporal analyses of germ cell mutations using the MutaMouse model support the recommended design in OECD test guideline 488.

Archives of toxicology·2025
Same author

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT).

Environmental and molecular mutagenesis·2024
Same author

Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.

Nature·2024

Area of Science:

  • Toxicology
  • Genetics
  • Biochemistry

Background:

  • Standard in vivo transgenic mutation assays require a waiting period between chemical treatment and sampling.
  • This waiting period allows mutation frequency to reach a maximum for accurate detection.
  • Recent findings indicate that some chemicals cause a decline in mutant frequency during this period, reducing assay sensitivity.

Purpose of the Study:

  • To address the reduced sensitivity of standard transgenic mutation assays.
  • To propose alternative protocols for maintaining assay sensitivity for all chemical mutagens.
  • To investigate the impact of treatment duration on mutation frequency detection.

Main Methods:

  • Review of existing evidence on chemical mutagenicity testing protocols.

Related Experiment Videos

  • Analysis of factors influencing mutant frequency over time post-treatment.
  • Development of modified treatment-sampling protocols for in vivo assays.

    • Main Results:

    • The standard assay protocol's sensitivity can be compromised by chemical-specific declines in mutant frequency.
    • Continuing chemical treatment until the time of sampling is identified as a potential method to counteract this decline.
    • Proposed protocols aim to optimize sensitivity for both increasing and decreasing mutant frequency scenarios.

    Conclusions:

    • The standard waiting period in transgenic mutation assays is not universally optimal.
    • Modifying treatment protocols, specifically by continuing treatment until sampling, can enhance assay sensitivity.
    • Implementing revised protocols ensures more reliable detection of chemical mutagens in vivo.